Mauna Kea Technologies S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MKEAF research report →
Companywww.maunakeatech.com
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level.
- CEO
- Alexandre Loiseau
- IPO
- 2013
- Employees
- 65
- HQ
- Paris, FR
Price Chart
Valuation
- Market Cap
- $25.87M
- P/E
- 2.88
- P/S
- 1.68
- P/B
- -6.03
- EV/EBITDA
- -3.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 76.31%
- Op Margin
- -71.17%
- Net Margin
- 117.81%
- ROE
- -58.93%
- ROIC
- -73.74%
Growth & Income
- Revenue
- $7.66M · -30.58%
- Net Income
- $-10,404,000 · -179.15%
- EPS
- $-0.15 · -108.33%
- Op Income
- $-6,049,000
- FCF YoY
- -476.12%
Performance & Tape
- 52W High
- $0.37
- 52W Low
- $0.37
- 50D MA
- $0.37
- 200D MA
- $0.37
- Beta
- 1.05
- Avg Volume
- 4.14K
Get TickerSpark's AI analysis on MKEAF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MKEAF Coverage
We haven't published any research on MKEAF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MKEAF Report →